Cytokeratin 8 Activators

Common Cytokeratin 8 Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, Dexamethasone CAS 50-02-2, Tamoxifen CAS 10540-29-1, β-Estradiol CAS 50-28-2 and Insulin CAS 11061-68-0.

Cytokeratin 8 activators is a class of chemical compounds associated with the regulation of the cytokeratin 8 gene (CK8). Cytokeratins are a family of intermediate filament proteins found in epithelial cells, providing structural support and stability to these cells. CK8, a member of the cytokeratin family, is particularly abundant in simple epithelial cells, which line various body surfaces, including the liver, pancreas, lung, and gastrointestinal tract. CK8 plays a crucial role in maintaining cell integrity and providing resilience to mechanical stress. The study of CK8 activators is instrumental in understanding the regulatory mechanisms governing the expression of CK8, which, in turn, sheds light on the biology of epithelial tissues.

Activators of CK8 typically are compounds or factors that influence the transcription or expression of the CK8 gene. These activators can modulate CK8 levels within cells and tissues. The regulation of CK8 expression is essential for maintaining epithelial cell function and integrity, as alterations in CK8 levels can impact the structural properties and stress resistance of these cells. Understanding the molecular mechanisms that control CK8 expression and identifying compounds that can activate this gene can provide valuable insights into the biology of epithelial tissues, as well as potential strategies for studying or manipulating cell structure and function in various research contexts. CK8 activators, therefore, serve as tools for investigating the intricate mechanisms governing epithelial cell biology.